A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day of each week.
Micro-titration: a disputed topic, argued properly — one year on posts 31–60
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
I think the Micro-titration question is answerable and has not been answered, which is a more optimistic position than most of this thread.
On post #31 — agreed on the reasoning, with one qualification.
The four-week step is a trial convention, not a pharmacological constant. It is roughly four half-lives for a week-long half-life, which is the interval at which you are assessing a stable concentration rather than a rising one.
Same conclusion as the reply above, reached differently, which is mildly reassuring.
Collapsed as off-topic by two members at trust level 3 or above
Seconded. It reads as careful rather than confident, which is the right register.
Worth separating two things that post #35 runs together.
The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat it as one.
That has held every time I have looked, which is not the same as always.
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Everything in post #35 holds. The case it does not cover is the one I have.
Micro-titration sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Narrowing post #39, because the general version has more than one answer.
Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been studied clinically. One mg of semaglutide is not equivalent to one mg of something else in any meaningful sense.
Written from notes rather than memory, which is why the numbers are specific.
Collapsed as off-topic by two members at trust level 3 or above
Worth separating two things that post #38 runs together.
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Noting that I have skin in this question and have tried to discount for it.
Two questions I would want answered before drawing anything from the Micro-titration data above: how were the cases selected, and what happened to the ones that dropped out.
On Micro-titration the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Post #43 and I disagree about the size of the effect, not about the direction.
A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day of each week.
Speaking for myself and not for anyone else who has posted here.
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Nothing here is medical advice, and a titration question is one of the few where a prescriber can genuinely answer in a minute what a thread will take a week to circle.
Someone should write this up properly, and it should probably not be me.
Post #49 put the caveat in the right place and I want to underline it.
The claim about Micro-titration upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been studied clinically. One mg of semaglutide is not equivalent to one mg of something else in any meaningful sense.
Anyone who has looked at this more carefully, please correct the record.
The arithmetic in post #53 is right; the assumption feeding it is the part to check.
My understanding of Micro-titration is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by real-world reports. The dose does not seem to stop working, but the longest trials are not indefinitely long.
Everything in post #53 holds. The case it does not cover is the one I have.
Micro-titration has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
Useful. I had the fact and not the reason, which turns out to be the important half.
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Confirming post #57 from a second method, which matters more than confirming it from a second person.
Offering a way to settle Micro-titration rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise, the question was not answerable at this precision.